← Leaderboards
Alan K Lichtenstein
Brentwood Biomedical Research Institute
$7,859,017
Attributed
$8,523,012
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $784.6K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$8,523,012 · 8
VA$0 · 1
By mechanism
R01$7,037,645 · 5
R21$1,485,367 · 3
I01$0 · 1
Top collaborators
- Joseph F Gera5 shared
Others in their field
Top investigators on “Multiple Myeloma”
- David Heimbrook · Leidos Biomedical Research, Inc.$146,380,351
- Larry Arthur$41,717,333
- Charles A Coltman · Southwest Oncology Group$36,988,659
- Kenneth C Anderson · Dana-Farber Cancer Inst$25,497,347
- Irene M. Ghobrial · Dana-Farber Cancer Inst$22,402,686
- Nilsa Del Carmen Ramirez · Ohio State University$22,287,552
Research focus
Multiple MyelomaCellsPreventMalignant NeoplasmsProteinsPhosphotransferasesPhosphorylationMolecularInhibitor/AntagonistFutureComplexTranslationsMtor InhibitorProtein ExpressionMediatingPharmaceutical PreparationsEventSirolimusDesignResponseApoptosisProto-Oncogene Proteins C-AktHybridsPathway Interactions
Grant awards (41)
Targeting DEPTOR in multiple myeloma$288,225
R01 · FY2021 · CA · contact PI
Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses$288,225
R01 · FY2021 · CA · contact PI
Targeting DEPTOR in multiple myeloma$288,225
R01 · FY2020 · CA · contact PI
Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses$288,225
R01 · FY2020 · CA · contact PI
Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses$293,689
R01 · FY2019 · CA · contact PI
Targeting DEPTOR in multiple myeloma$279,577
R01 · FY2019 · CA · contact PI
Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses$302,774
R01 · FY2018 · CA · contact PI
Targeting DEPTOR in multiple myeloma$288,225
R01 · FY2018 · CA · contact PI
Targeting of DEPTOR in Multiple Myeloma$0
I01 · FY2018 · VA · contact PI
Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses$308,722
R01 · FY2017 · CA · contact PI
Targeting DEPTOR in multiple myeloma$288,225
R01 · FY2017 · CA · contact PI
Targeting of DEPTOR in Multiple Myeloma$0
I01 · FY2017 · VA · contact PI
Sensitivity of multiple myeloma cells to mTOR inhibitors$184,270
R01 · FY2016 · CA · contact PI
Targeting TORC2 in Multiple Myeloma$0
I01 · FY2016 · VA · contact PI
Sensitivity of multiple myeloma cells to mTOR inhibitors$184,270
R01 · FY2015 · CA · contact PI
Targeting TORC2 in Multiple Myeloma$0
I01 · FY2015 · VA · contact PI
Sensitivity of multiple myeloma cells to mTOR inhibitors$178,742
R01 · FY2014 · CA · contact PI
Targeting DEPTOR in multiple myeloma$168,780
R21 · FY2014 · CA · contact PI
Targeting TORC2 in Multiple Myeloma$0
I01 · FY2014 · VA · contact PI
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo$249,066
R01 · FY2013 · CA
Sensitivity of multiple myeloma cells to mTOR inhibitors$173,214
R01 · FY2013 · CA · contact PI
Targeting DEPTOR in multiple myeloma$133,763
R21 · FY2013 · CA · contact PI
Targeting TORC2 in Multiple Myeloma$0
I01 · FY2013 · VA · contact PI
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo$264,964
R01 · FY2012 · CA
Sensitivity of multiple myeloma cells to mTOR inhibitors$184,270
R01 · FY2012 · CA · contact PI
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo$264,964
R01 · FY2011 · CA
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo$273,159
R01 · FY2010 · CA
Use of CCI-779 in multiple myeloma$319,950
R21 · FY2009 · CA · contact PI
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo$275,837
R01 · FY2009 · CA
Sensitivity Multiple Myeloma Cells to mTOR Inhibitors$188,765
R01 · FY2009 · CA · contact PI
Use of CCI-779 in multiple myeloma$319,950
R21 · FY2008 · CA · contact PI
Sensitivity Multiple Myeloma Cells to mTOR Inhibitors$188,765
R01 · FY2008 · CA · contact PI
Sensitivity Multiple Myeloma Cells to mTOR Inhibitors$188,765
R01 · FY2007 · CA · contact PI
EBV lytic re-activation in nasopharyngeal carcinoma$262,979
R21 · FY2006 · CA · contact PI
Sensitivity Multiple Myeloma Cells to mTOR Inhibitors$194,402
R01 · FY2006 · CA · contact PI
EBV lytic re-activation in nasopharyngeal carcinoma$279,945
R21 · FY2005 · CA
The AKT-mTOR Pathway in Multiple Myeloma$232,750
R01 · FY2005 · CA
Sensitivity Multiple Myeloma Cells to mTOR Inhibitors$199,080
R01 · FY2005 · CA
The AKT-mTOR Pathway in Multiple Myeloma$232,750
R01 · FY2004 · CA
The AKT-mTOR Pathway in Multiple Myeloma$232,750
R01 · FY2003 · CA
The AKT-mTOR Pathway in Multiple Myeloma$232,750
R01 · FY2002 · CA